Pharma Acquisition

Seeking Mid-Sized Pharma Acquisitions

Business Type: API (Active Pharmaceutical Ingredient) and formulation manufacturers
Location: Gujarat, Maharashtra, or Himachal Pradesh
Revenue Range: ₹50–100 crore
Profitability: Positive EBITDA
Operational History: Minimum of 5 years in compliant pharmaceutical operations
Licensing: Must be fully licensed and operational

Connect with Us

Identifying Licensed Pharma Manufacturers for Strategic Acquisition

We are actively seeking to acquire licensed, operational API and formulation manufacturing companies in India, specifically in Gujarat, Maharashtra, and Himachal Pradesh. Target companies should have revenues between ₹50–100 crore, a positive EBITDA, and a track record of over five years in compliant pharmaceutical operations.

Strategic Pharma Expansion Through Targeted Acquisitions

We are acquiring established API and formulation manufacturers in India with strong compliance, positive EBITDA, and ₹50–100 crore revenue.

Focused Buyout of Licensed Manufacturing Units

Targeting pharma companies in Gujarat, Maharashtra, and Himachal Pradesh with a five-year operational track, regulatory approvals, and stable margins.

Scaling Presence via Mid-Market Pharma Deals

Looking to acquire growth-ready formulation and API firms that meet compliance, financial health, and geographic criteria for strategic scale-up.

Pharma M&A: Operational Strength Meets Compliance

Seeking manufacturers with end-to-end capabilities, regulatory licenses, and consistent financial performance to support long-term pharma growth objectives.

Expanding Through Strategic Pharma Manufacturing Acquisitions

A prominent security company in India sought to explore strategic options, including mergers and acquisitions, to capitalize on growth opportunities in the security services industry.

M&A in the Pharma Sector

Amros Consulting is actively pursuing strategic acquisitions in India’s pharmaceutical manufacturing sector—specifically targeting API and formulation companies with strong compliance, positive EBITDA, and proven operational history. This aligns with our goal of enabling vertical integration, operational resilience, and market scalability.

Why Expansion Would Help the Company:

Amros provided end-to-end solutions for the M&A process.

By acquiring mid-sized, compliant pharma manufacturers, Amros Consulting aims to build integrated capabilities that support end-to-end delivery, improve reliability, and unlock growth across key Indian and international markets.

We are always ready for
your questions.

We deliver result-oriented integrated solutions through our broad-based services, including investment advisory, equity financing, market entry, M&A, strategic insights, marketing strategies, corporate finance and communication, among others, across sectors and geographies.

Quick Link

Information

get in touch

Social media :